These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 8531917)
1. Hepatitis A among persons with hemophilia who received clotting factor concentrate--United States, September-December 1995. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1996 Jan; 45(2):29-32. PubMed ID: 8531917 [TBL] [Abstract][Full Text] [Related]
2. From the Centers for Disease Control and Prevention. Hepatitis A among persons with hemophilia who received clotting factor concentrate--United States, September-December 1995. JAMA; 1996 Feb; 275(6):427-8. PubMed ID: 8627951 [No Abstract] [Full Text] [Related]
3. An outbreak of hepatitis A among South African patients with hemophilia: evidence implicating contaminated factor VIII concentrate as the source. Kedda MA; Kew MC; Cohn RJ; Field SP; Schwyzer R; Song E; Fernandes-Costa F Hepatology; 1995 Nov; 22(5):1363-7. PubMed ID: 7590648 [TBL] [Abstract][Full Text] [Related]
4. Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States? Mosley JW Vox Sang; 1994; 67 Suppl 4():12-5; discussion 24-6. PubMed ID: 7831863 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis A virus sequence detected in clotting factor concentrates associated with disease transmission. Robertson BH; Alter MJ; Bell BP; Evatt B; McCaustland KA; Shapiro CN; Sinha SD; Souci JM Biologicals; 1998 Jun; 26(2):95-9. PubMed ID: 9811512 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C and pasteurised factor VIII and IX concentrates. Klarmann D; Kreuz W; Auerswald G; Auberger K; Rabenau H; Gürtler L; Roggendorf M Thromb Haemost; 1995 Apr; 73(4):736-7. PubMed ID: 7495095 [No Abstract] [Full Text] [Related]
7. Virology of the hepatitis A epidemic in Italy. Purcell RH; Mannucci PM; Gdovin S; Gringeri A; Colombo M; Mele A; Schinaia N; Ciavarella N; Emerson SU Vox Sang; 1994; 67 Suppl 4():2-7; discussion 24-6. PubMed ID: 7831866 [TBL] [Abstract][Full Text] [Related]
8. Progress in the clinical management of haemophilia. Bloom AL Thromb Haemost; 1991 Jul; 66(1):166-77. PubMed ID: 1926047 [No Abstract] [Full Text] [Related]
9. Hepatitis A virus infections associated with clotting factor concentrate in the United States. Soucie JM; Robertson BH; Bell BP; McCaustland KA; Evatt BL Transfusion; 1998 Jun; 38(6):573-9. PubMed ID: 9661691 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis A virus infection among the hemophilia population at the Bonn Hemophilia Center. Brackmann HH; Oldenburg J; Eis-Hübinger AM; Gerritzen A; Hammerstein U; Hanfland P Vox Sang; 1994; 67 Suppl 1():3-7; discussion 8. PubMed ID: 8091733 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease. Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757 [TBL] [Abstract][Full Text] [Related]
12. Review of the hepatitis A epidemics in hemophiliacs in Europe. Vermylen J; Peerlinck K Vox Sang; 1994; 67 Suppl 4():8-11; discussion 24-6. PubMed ID: 7831867 [TBL] [Abstract][Full Text] [Related]
13. HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate. Remis RS; O'Shaughnessy MV; Tsoukas C; Growe GH; Schechter MT; Palmer RW; Lawrence DN CMAJ; 1990 Jun; 142(11):1247-54. PubMed ID: 2111726 [TBL] [Abstract][Full Text] [Related]
14. Recombinant factor VIII in hemophilia A: the Canadian experience. Blanchette VS Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S33-9. PubMed ID: 9351535 [TBL] [Abstract][Full Text] [Related]
15. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group. Mannucci PM; Gdovin S; Gringeri A; Colombo M; Mele A; Schinaia N; Ciavarella N; Emerson SU; Purcell RH Ann Intern Med; 1994 Jan; 120(1):1-7. PubMed ID: 7504424 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran). Mansour-Ghanaei F; Fallah MS; Shafaghi A; Yousefi-Mashhoor M; Ramezani N; Farzaneh F; Nassiri R Med Sci Monit; 2002 Dec; 8(12):CR797-800. PubMed ID: 12503038 [TBL] [Abstract][Full Text] [Related]
17. The outbreak of hepatitis A in Italian patients with hemophilia: facts and fancies. Mannucci PM; Santagostino E; Di Bona E; Gentili G; Ghirardini A; Schiavoni M; Mele A Vox Sang; 1994; 67 Suppl 1():31-5. PubMed ID: 8091734 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of the factor VIII/von Willebrand factor concentrate, haemate-P/humate-P: ristocetin cofactor unit dosing in patients with von Willebrand disease. Lillicrap D; Poon MC; Walker I; Xie F; Schwartz BA; Thromb Haemost; 2002 Feb; 87(2):224-30. PubMed ID: 11858481 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of hemophilia A with actor VIII concentrate in urological operations and injuries of the urinary tract]. Brühl P; Weibbach L; Brackmann HH MMW Munch Med Wochenschr; 1975 Mar; 117(10):401-4. PubMed ID: 804604 [TBL] [Abstract][Full Text] [Related]
20. [Oral administration of factor VIII or IX concentrate preparation]. Sakuragawa N Rinsho Ketsueki; 1985 Jul; 26(7):1086-9. PubMed ID: 3932721 [No Abstract] [Full Text] [Related] [Next] [New Search]